Latest news on Processingtalk categorised by supplier
Amersin Life Sciences
Address:
410 Park Avenue
15th floor
New York
NY 10022
USA
Telephone: (USA) +1 604 881 2899
http://www.amersin.com
Our RSS feed for news from Amersin Life Sciences
Request to receive our free email newsletter each week
Listing of all 6 news releases from Amersin Life Sciences:
Contract for Sri Lanka relief aid pharmaceuticals
Amersin Life Sciences has entered into a sales contract valued at 6.4 million RMB for pharmaceuticals to aid Sri Lanka as part of the China's tsunami relief programme
News from Amersin Life Sciences (31 January 2005)
Amersin Life Sciences Corporation is born
Amersin Life Sciences Corporation announces a new trading symbol and the completion of name change from the Hubei Pharmaceutical Group.
News from Amersin Life Sciences (17 January 2005)
Hubei Pharmaceutical renamed Amersin Life Sciences
Hubei Pharmaceutical Group Ltd announced today that the company name will be changed to Amersin Life Sciences Corporation, to reflect the business and diversification plans of the company
News from Amersin Life Sciences (18 November 2004)
Injection production facilities certificated
HBBenda JV has been granted an operating license for pharmaceutical research and development: initial production has commenced and they have been granted GMP certification to the latest standards
News from Amersin Life Sciences (13 July 2004)
Hubei Pharmaceutical Group expands by acquisition
Hubei Pharmaceutical Group has entered into a formal agreement to acquire a 60% controlling interest in HBBenda, a JV for production of high-tech pharmaceutical products in injectable and tablet forms
News from Amersin Life Sciences ( 8 June 2004)
New long-term effect contraceptive announced
Hubei Pharmaceutical Group announced today that its joint venture subsidiary, Hubei Pharmaceutical Company, located in Hubei Province, China has released Nuotinyu, a new long-term effect contraceptive
News from Amersin Life Sciences (14 May 2004)
